Establishment of new diagnostic Biomarker and Characterization of protective bone marrow niche in patients with multiple myeloma
- Conditions
- C90Multiple myeloma and malignant plasma cell neoplasms
- Registration Number
- DRKS00010830
- Lead Sponsor
- niversitätsklinikum Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
=18 years
-Symptomatic, IMiD-treated MM patients
-MM patients under anti-myeloma therapy, containing IMiDs (vs. as controls other novel antimyeloma agents)
-Routine bone marrow puncture during MM patient treatment course with IMiDs
-Healthy persons undergoing bone surgery
Exclusion Criteria
-<18 years of age
-Any kind of health and/or psychological problems which withhold the patient to understand and give his/her written informed consent to use the BM sample for this research project
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method